Mylan sets sights on production of generic asthma inhaler – Tribune-Review


Yahoo News

Mylan sets sights on production of generic asthma inhaler
Tribune-Review
Besides providing a cheaper alternative for asthma sufferers across the country, being first to market with generic Advair is seen as key to Mylan's drive to boost growth and hit an ambitious earnings target of adjusted net income of at least $6 a
Mylan: Advair Generic Ready For LaunchBusiness Finance News

all 16 news articles »

View full post on asthma – Google News

Sonchus asper extract inhibits LPS-induced oxidative stress and pro-inflammatory cytokine production in RAW264.7 macrophages.

Related Articles

Sonchus asper extract inhibits LPS-induced oxidative stress and pro-inflammatory cytokine production in RAW264.7 macrophages.

Nutr Res Pract. 2015 Dec;9(6):579-585

Authors: Wang L, Xu ML, Liu J, Wang Y, Hu JH, Wang MH

Abstract
BACKGROUND/OBJECTIVES: Sonchus asper is used extensively as an herbal anti-inflammatory for treatment of bronchitis, asthma, wounds, burns, and cough; however, further investigation is needed in order to understand the underlying mechanism. To determine its mechanism of action, we examined the effects of an ethyl acetate fraction (EAF) of S. asper on nitric oxide (NO) production and prostaglandin-E2 levels in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages.
MATERIALS/METHODS: An in vitro culture of RAW264.7 macrophages was treated with LPS to induce inflammation.
RESULTS: Treatment with EAF resulted in significant suppression of oxidative stress in RAW264.7 macrophages as demonstrated by increased endogenous superoxide dismutase (SOD) activity and intracellular glutathione levels, decreased generation of reactive oxygen species and lipid peroxidation, and restoration of the mitochondrial membrane potential. To confirm its anti-inflammatory effects, analysis of expression of inducible NO synthase, cyclooxygenase-2, tumor necrosis factor-?, and the anti-inflammatory cytokines IL-1? and IL-6 was performed using semi-quantitative RT-PCR. EAF treatment resulted in significantly reduced dose-dependent expression of all of these factors, and enhanced expression of the antioxidants MnSOD and heme oxygenase-1. In addition, HPLC fingerprint results suggest that rutin, caffeic acid, and quercetin may be the active ingredients in EAF.
CONCLUSIONS: Taken together, findings of this study imply that the anti-inflammatory effect of EAF on LPS-stimulated RAW264.7 cells is mediated by suppression of oxidative stress.

PMID: 26634045 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Epithelial regulation of eicosanoid production in asthma.

Related Articles

Epithelial regulation of eicosanoid production in asthma.

Pulm Pharmacol Ther. 2012 Dec;25(6):432-7

Authors: Hallstrand TS, Lai Y, Henderson WR, Altemeier WA, Gelb MH

Abstract
Alterations in the airway epithelium have been associated with the development of asthma in elite athletes and in subjects that are susceptible to exercise-induced bronchoconstriction (EIB). The syndrome of EIB refers to acute airflow obstruction that is triggered by a period of physical exertion. Asthmatics who are susceptible to EIB have increased levels of cysteinyl leukotrienes (CysLTs, i.e., LTs C?, D?, and E?) in induced sputum and exhaled breath condensate, and greater shedding of epithelial cells into the airway lumen. Exercise challenge in individuals susceptible to this disorder initiates a sustained increase in CysLTs in the airways, and secreted mucin release and smooth muscle constriction, which may be mediated in part through activation of sensory nerves. We have identified a secreted phospholipase A? (sPLA?) with increased levels in the airways of patients with EIB called sPLA? group X(sPLA?-X).We have found that sPLA?-X is strongly expressed in the airway epithelium in asthma. Further,we discovered that transglutaminase 2 (TGM2) is expressed at increased levels in asthma and serves asa regulator of sPLA?-X. Finally, we demonstrated that sPLA?-X acts on target cells such as eosinophils to initiate cellular eicosanoid synthesis. Collectively, these studies identify a novel mechanism linking the airway epithelium to the production of inflammatory eicosanoids by leukocytes.

PMID: 23323271 [PubMed – in process]

View full post on pubmed: asthma

Astra ends production of asthma inhaler – Newsday (subscription)

Astra ends production of asthma inhaler
Newsday (subscription)
By AP (AP) — AstraZeneca PLC is ending production of one version of its asthma drug Pulmicort immediately because of technical problems in manufacturing. Astra's announcement on Monday sent shares in its technology partner for the drug, SkyePharma,
SkyePharma Shares Fall As AstraZeneca Drops Asthma ProductWall Street Journal
SkyePharma crashesThis is London
AZ discontinues inhaler on 'technical issues'FiercePharma

all 54 news articles »

View full post on asthma – Google News

Astra ends production of asthma inhaler – BusinessWeek

Astra ends production of asthma inhaler
BusinessWeek
AstraZeneca PLC is ending production of one version of its asthma drug Pulmicort immediately because of technical problems in manufacturing. Astra's announcement on Monday sent shares in its technology partner for the drug, SkyePharma,
Astra pulls asthma product, hitting SkyePharmaReuters
AstraZeneca withdraws asthma drugManchester Evening News
AZ withdraws asthma drug, bad news for SkyePharmaPharma Times
InPharm –Telegraph.co.uk –In-PharmaTechnologist.com
all 51 news articles »

View full post on asthma – Google News